Charles Schwab
TVGN icon

Charles Schwab’s Tevogen Inc TVGN Stock Holding History

Charles Schwab’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,642
Closed -$27.2K – 3532
2025
Q4 		$27.2K Buy
1,642
+112
+7% +$2.91K ﹤0.01% 3449
2025
Q3 		$60.1K Hold
1,530
– – ﹤0.01% 3418
2025
Q2 		$95.6K Buy
1,530
+537
+54% +$30.6K ﹤0.01% 3417
2025
Q1 		$53.6K Buy
993
+1
+0.1% +$66 ﹤0.01% 3396
2024
Q4 		$51.1K Hold
992
– – ﹤0.01% 3437
2024
Q3 		$18.3K Hold
992
– – ﹤0.01% 3486
2024
Q2 		$35.9K Buy
+992
New +$64.6K ﹤0.01% 3552

Other funds holding TVGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Charles Schwab's TVGN Position: Q1 2026 in Review

Charles Schwab sold out of Tevogen Inc (TVGN) in Q1 2026, closing a stake of 1,642 shares — an estimated $27.2K sold.

Charles Schwab first reported a position in TVGN in Q2 2024 and held it in 7 quarters. The position peaked at $95.6K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Charles Schwab reported no remaining Tevogen Inc position as of Q1 2026 after selling out during the quarter.
  • Charles Schwab sold 1,642 Tevogen Inc shares in Q1 2026, an estimated $27.2K.
  • Charles Schwab first reported a position in Tevogen Inc in Q2 2024 and held it in 7 quarters.
  • Charles Schwab's Tevogen Inc position peaked at $95.6K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.